Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6121)
All Articles published online
|
Publishing Process of This Article
|
Oct 7, 2014 (publication date) through Apr 19, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Marengo E, Robotti E. Biomarkers for pancreatic cancer: Recent achievements in proteomics and genomics through classical and multivariate statistical methods. World J Gastroenterol 2014; 20(37): 13325-13342 [PMID: 25309068 DOI: 10.3748/wjg.v20.i37.13325] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i37/13325.htm |
| Number | Citing Articles |
| 1 |
Li Jiao, Suman Maity, Cristian Coarfa, Kimal Rajapakshe, Liang Chen, Feng Jin, Vasanta Putluri, Lesley F. Tinker, Qianxing Mo, Fengju Chen, Subrata Sen, Haleh Sangi-Hyghpeykar, Hashem B. El-Serag, Nagireddy Putluri. A Prospective Targeted Serum Metabolomics Study of Pancreatic Cancer in Postmenopausal Women. Cancer Prevention Research 2019; 12(4): 237 doi: 10.1158/1940-6207.CAPR-18-0201
|
| 2 |
Carla Proietti, Lutz Krause, Angela Trieu, Daniel Dodoo, Ben Gyan, Kwadwo A. Koram, William O. Rogers, Thomas L. Richie, Peter D. Crompton, Philip L. Felgner, Denise L. Doolan. Immune Signature Against Plasmodium falciparum Antigens Predicts Clinical Immunity in Distinct Malaria Endemic Communities. Molecular & Cellular Proteomics 2020; 19(1): 101 doi: 10.1074/mcp.RA118.001256
|
| 3 |
Ali Bodaghi, Nadia Fattahi, Ali Ramazani. Biomarkers: Promising and valuable tools towards diagnosis, prognosis and treatment of Covid-19 and other diseases. Heliyon 2023; 9(2): e13323 doi: 10.1016/j.heliyon.2023.e13323
|
| 4 |
Atanu Bhattacharjee, Gajendra K. Vishwakarma, Abin Thomas. Bayesian state-space modeling in gene expression data analysis: An application with biomarker prediction. Mathematical Biosciences 2018; 305: 96 doi: 10.1016/j.mbs.2018.08.011
|
| 5 |
Jake W. Pawlowski, Ian Carrick, Igor A. Kaltashov. Integration of On-Column Chemical Reactions in Protein Characterization by Liquid Chromatography/Mass Spectrometry: Cross-Path Reactive Chromatography. Analytical Chemistry 2018; 90(2): 1348 doi: 10.1021/acs.analchem.7b04328
|
| 6 |
Kazufumi Honda, Michimoto Kobayashi, Takuji Okusaka, Jo Ann Rinaudo, Ying Huang, Tracey Marsh, Mitsuaki Sanada, Yoshiyuki Sasajima, Shoji Nakamori, Masashi Shimahara, Takaaki Ueno, Akihiko Tsuchida, Naohiro Sata, Tatsuya Ioka, Yohichi Yasunami, Tomoo Kosuge, Nami Miura, Masahiro Kamita, Takako Sakamoto, Hirokazu Shoji, Giman Jung, Sudhir Srivastava, Tesshi Yamada. Plasma biomarker for detection of early stage pancreatic cancer and risk factors for pancreatic malignancy using antibodies for apolipoprotein-AII isoforms. Scientific Reports 2015; 5(1) doi: 10.1038/srep15921
|
| 7 |
Jeffery Ho, Xianchun Li, Lin Zhang, Yonghao Liang, Wei Hu, Johnny C.W. Yau, Hung Chan, Tony Gin, Matthew T.V. Chan, Gary Tse, William K.K. Wu. Translational genomics in pancreatic ductal adenocarcinoma: A review with re-analysis of TCGA dataset. Seminars in Cancer Biology 2019; 55: 70 doi: 10.1016/j.semcancer.2018.04.004
|
| 8 |
Mengsi Yu, Kainan Zhang, Song Wang, Li Xue, Zhaoyun Chen, Ning Feng, Conghua Ning, Lijuan Wang, Jing Li, Boke Zhang, Changcheng Yang, Zhaoxia Zhang, Maria Irene Bellini. Increased SPHK1 and HAS2 Expressions Correlate to Poor Prognosis in Pancreatic Cancer. BioMed Research International 2021; 2021: 1 doi: 10.1155/2021/8861766
|
| 9 |
Wenyan Guo, Jing Bai, Qingning Zhang, Kunfeng Duan, Panpan Zhang, Jianghua Zhang, Jing Zhao, Wei Zhang, Dezhi Kong. Influence of thermal processing on the quality of hawthorn: Quality markers of heat‐processed hawthorn. Journal of Separation Science 2022; 45(19): 3774 doi: 10.1002/jssc.202200222
|
| 10 |
Sumit Sahni, Advait R. Pandya, William J. Hadden, Christopher B. Nahm, Sarah Maloney, Victoria Cook, James A. Toft, Lorna Wilkinson‐White, Anthony J. Gill, Jaswinder S. Samra, Anthony Dona, Anubhav Mittal. A unique urinary metabolomic signature for the detection of pancreatic ductal adenocarcinoma. International Journal of Cancer 2021; 148(6): 1508 doi: 10.1002/ijc.33368
|
| 11 |
Hua Zhong, Shuai Liu, Jingjing Zhu, Lang Wu. Associations between genetically predicted levels of blood metabolites and pancreatic cancer risk. International Journal of Cancer 2023; 153(1): 103 doi: 10.1002/ijc.34466
|
| 12 |
Shuo Wang, Jiang Chen, Hongyu Li, Xingshun Qi, Xu Liu, Xiaozhong Guo. Metabolomic Detection Between Pancreatic Cancer and Liver Metastasis Nude Mouse Models Constructed by Using the PANC1-KAI1/CD82 Cell Line. Technology in Cancer Research & Treatment 2021; 20: 153303382110452 doi: 10.1177/15330338211045204
|
| 13 |
Roxana Cristina Popescu, Mariana Oana Mihaela Fufă, Ecaterina Andronescu, Alexandru Mihai Grumezescu. Nanobiomaterials in Medical Imaging. 2016; : 1 doi: 10.1016/B978-0-323-41736-5.00001-7
|
| 14 |
Sari F Alhasan, Beate Haugk, Laura F Ogle, Gary S Beale, Anna Long, Alastair D Burt, Dina Tiniakos, Despina Televantou, Fareeda Coxon, David R Newell, Richard Charnley, Helen L Reeves. Sulfatase-2: a prognostic biomarker and candidate therapeutic target in patients with pancreatic ductal adenocarcinoma. British Journal of Cancer 2016; 115(7): 797 doi: 10.1038/bjc.2016.264
|
| 15 |
S. Battini, F. Faitot, A. Imperiale, A. E. Cicek, C. Heimburger, G. Averous, P. Bachellier, I. J. Namer. Metabolomics approaches in pancreatic adenocarcinoma: tumor metabolism profiling predicts clinical outcome of patients. BMC Medicine 2017; 15(1) doi: 10.1186/s12916-017-0810-z
|
| 16 |
Tatsuya Kitagawa, Keisuke Taniuchi, Makiko Tsuboi, Masahiko Sakaguchi, Takuhiro Kohsaki, Takehiro Okabayashi, Toshiji Saibara. Circulating pancreatic cancer exosomal RNAs for detection of pancreatic cancer. Molecular Oncology 2019; 13(2): 212 doi: 10.1002/1878-0261.12398
|
| 17 |
Jinfeng Xiang, Liang Liu, Wenquan Wang, Huaxiang Xu, Chuntao Wu, Jin Xu, Chen Liu, Jiang Long, Quanxing Ni, Xianjun Yu. Metabolic tumor burden: A new promising way to reach precise personalized therapy in PDAC. Cancer Letters 2015; 359(2): 165 doi: 10.1016/j.canlet.2015.01.023
|
| 18 |
Marcello Manfredi, Carmela Chiariello, Eleonora Conte, Annalisa Castagna, Elisa Robotti, Fabio Gosetti, Mauro Patrone, Nicola Martinelli, Antonella Bassi, Daniela Cecconi, Emilio Marengo, Oliviero Olivieri. Plasma Proteome Profiles of Stable CAD Patients Stratified According to Total Apo C‐III Levels. PROTEOMICS – Clinical Applications 2019; 13(3) doi: 10.1002/prca.201800023
|
| 19 |
Hua Li, Xiangdong Tian, Yong Xu, Yi Pan, Yubei Huang, Dejun Zhou, Zhenguo Song. Prognostic value of pre‑treatment peripheral blood markers in pancreatic ductal adenocarcinoma and their association with S100A4 expression in tumor tissue. Oncology Letters 2019; doi: 10.3892/ol.2019.10809
|